https://www.sciencedaily.com/news/mind_brain/caregiving/ Make informed caregiving and home health care choices for your loved ones. Read the latest research for caregivers on caregiving. en-us Wed, 15 Apr 2026 09:43:23 EDT Wed, 15 Apr 2026 09:43:23 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/mind_brain/caregiving/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260414075648.htm A lifetime of mental stimulation—like reading, writing, and learning new skills—may help protect the brain as we age. People with the highest levels of cognitive enrichment had a much lower risk of Alzheimer’s and experienced symptoms years later than those with the lowest levels. Wed, 15 Apr 2026 04:09:05 EDT https://www.sciencedaily.com/releases/2026/04/260414075648.htm https://www.sciencedaily.com/releases/2026/04/260411043048.htm Losing your sense of smell might signal Alzheimer’s far earlier than expected. Scientists found that immune cells in the brain actively destroy smell-related nerve fibers after detecting abnormal signals on their surfaces. This damage begins in early stages of the disease, well before cognitive decline. The discovery could help identify at-risk patients sooner and improve treatment timing. Sat, 11 Apr 2026 08:13:19 EDT https://www.sciencedaily.com/releases/2026/04/260411043048.htm https://www.sciencedaily.com/releases/2026/04/260409101111.htm Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits. Scientists are now pushing toward multi-pronged strategies, from gene editing to brain-cell rejuvenation and gut health interventions. The goal: stop treating Alzheimer’s as one disease and start tackling it as a complex system. Fri, 10 Apr 2026 10:12:15 EDT https://www.sciencedaily.com/releases/2026/04/260409101111.htm https://www.sciencedaily.com/releases/2026/04/260408225933.htm Scientists have uncovered a surprising new player in Alzheimer’s disease: a protein called CSE that helps produce tiny amounts of hydrogen sulfide gas in the brain. In experiments with genetically engineered mice, removing this protein led to memory loss, brain damage, and other hallmarks of Alzheimer’s, including weakened blood-brain barriers and reduced formation of new neurons. The findings suggest that this “rotten egg” gas, when carefully regulated, may actually protect brain cells and support memory. Wed, 08 Apr 2026 22:59:33 EDT https://www.sciencedaily.com/releases/2026/04/260408225933.htm https://www.sciencedaily.com/releases/2026/04/260406192922.htm Scientists at Oregon State University have captured something researchers have long struggled to see: the real-time chemical interactions that help drive Alzheimer’s disease. By watching how metal ions—especially copper—trigger harmful protein clumping in the brain, the team uncovered a clearer picture of how the disease develops at a molecular level. Tue, 07 Apr 2026 07:37:31 EDT https://www.sciencedaily.com/releases/2026/04/260406192922.htm https://www.sciencedaily.com/releases/2026/04/260406192913.htm A single week of intensive meditation and mind-body practices led to measurable changes across the brain and body. Researchers observed improved brain efficiency, boosted immune signaling, and increased natural pain relief chemicals in participants’ blood. The effects even promoted neuron growth and stronger brain connectivity. Surprisingly, the experience mirrored psychedelic-like brain states—without any drugs involved. Tue, 07 Apr 2026 03:56:04 EDT https://www.sciencedaily.com/releases/2026/04/260406192913.htm https://www.sciencedaily.com/releases/2026/04/260401071931.htm A surprising new study suggests that genetics may change how diet affects brain health—especially when it comes to Alzheimer’s risk. Researchers found that older adults carrying high-risk APOE gene variants didn’t show the expected cognitive decline if they ate relatively high amounts of meat. In fact, those with these genes who consumed the most meat had slower cognitive decline and lower dementia risk, challenging conventional dietary advice. Thu, 02 Apr 2026 13:54:07 EDT https://www.sciencedaily.com/releases/2026/04/260401071931.htm https://www.sciencedaily.com/releases/2026/03/260328043558.htm Scientists have developed a new gene therapy that quiets pain at its source in the brain—without the addictive risks of opioids. Using AI to map how pain is processed, they created a targeted “off switch” that mimics morphine’s benefits but skips its dangerous side effects. In early tests, it delivered lasting relief without affecting normal sensations. The discovery could mark a major step toward safer, non-addictive pain treatments. Sat, 28 Mar 2026 20:57:04 EDT https://www.sciencedaily.com/releases/2026/03/260328043558.htm https://www.sciencedaily.com/releases/2026/03/260328043556.htm After a stroke, the brain may do something surprisingly hopeful—it can “refresh” parts of itself. Researchers analyzing brain scans from over 500 stroke survivors found that while the damaged side of the brain appears to age faster, the opposite, unaffected side can actually look younger. This unexpected shift seems to reflect the brain’s effort to rewire itself, strengthening healthy regions to compensate for lost function. Sun, 29 Mar 2026 06:34:17 EDT https://www.sciencedaily.com/releases/2026/03/260328043556.htm https://www.sciencedaily.com/releases/2026/03/260325005920.htm Researchers have identified a crucial ion channel, TMEM175, that acts like an overflow valve in the cell’s recycling system. It regulates acidity inside lysosomes, ensuring they function properly. When TMEM175 is faulty, toxic buildup can occur, contributing to diseases like Parkinson’s. This breakthrough reveals a promising new target for future therapies. Thu, 26 Mar 2026 07:35:07 EDT https://www.sciencedaily.com/releases/2026/03/260325005920.htm https://www.sciencedaily.com/releases/2026/03/260324230102.htm Balance problems in aging and Parkinson’s may come from the body working too hard, not too little. Scientists found that the brain and muscles become overactive during even minor disturbances, yet this actually weakens balance recovery. At the same time, muscles can stiffen against each other, making movement less stable. This unexpected pattern could help predict who is more likely to fall. Wed, 25 Mar 2026 00:29:12 EDT https://www.sciencedaily.com/releases/2026/03/260324230102.htm https://www.sciencedaily.com/releases/2026/03/260323005526.htm Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two proteins that, when combined, triggers the destruction of brain cells and fuels memory loss. By using a new compound to break apart this deadly duo, researchers were able to slow disease progression, protect brain cells, and even reduce hallmark amyloid buildup. Mon, 23 Mar 2026 05:34:10 EDT https://www.sciencedaily.com/releases/2026/03/260323005526.htm https://www.sciencedaily.com/releases/2026/03/260317064457.htm A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the Fc fragment. This piece acts like a trigger, prompting microglia to clear harmful amyloid plaques. The finding could reshape how future Alzheimer’s therapies are designed. Tue, 17 Mar 2026 07:44:52 EDT https://www.sciencedaily.com/releases/2026/03/260317064457.htm https://www.sciencedaily.com/releases/2026/03/260317064444.htm Early life stress may set the stage for long-term digestive problems by disrupting the gut-brain connection. Studies in both mice and thousands of children found links to symptoms like pain, constipation, and IBS. Scientists discovered that different biological pathways control different gut issues, hinting at more personalized treatments in the future. The research also highlights how a child’s early environment can have lasting physical effects—not just emotional ones. Tue, 17 Mar 2026 22:08:54 EDT https://www.sciencedaily.com/releases/2026/03/260317064444.htm https://www.sciencedaily.com/releases/2026/03/260315225125.htm A new UCLA Health study suggests that long-term exposure to the pesticide chlorpyrifos may dramatically raise the risk of Parkinson’s disease. Researchers found that people living in areas with sustained exposure had more than 2.5 times the likelihood of developing the disorder. Lab experiments reinforced the finding: animals exposed to the chemical developed movement problems, lost dopamine-producing neurons, and showed the same toxic protein buildup seen in Parkinson’s patients. Mon, 16 Mar 2026 18:49:45 EDT https://www.sciencedaily.com/releases/2026/03/260315225125.htm https://www.sciencedaily.com/releases/2026/03/260313002637.htm Tiny plastic particles may be quietly threatening brain health. New research suggests microplastics—now widely found in food, water, and even household dust—could trigger inflammation and damage in the brain through multiple biological pathways. Scientists estimate adults may consume about 250 grams of these particles each year, and some can accumulate in organs including the brain. Fri, 13 Mar 2026 20:38:26 EDT https://www.sciencedaily.com/releases/2026/03/260313002637.htm https://www.sciencedaily.com/releases/2026/03/260312020104.htm A new study suggests Alzheimer’s disease may be detectable through subtle shape changes in proteins found in the blood. Researchers discovered that structural differences in three blood proteins closely track the progression of the disease. By analyzing these changes in more than 500 people, the team was able to distinguish healthy individuals from those with mild cognitive impairment or Alzheimer’s with impressive accuracy. The approach could help move diagnosis and treatment to earlier stages. Thu, 12 Mar 2026 07:00:56 EDT https://www.sciencedaily.com/releases/2026/03/260312020104.htm https://www.sciencedaily.com/releases/2026/03/260311004720.htm Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody infusions like current therapies, the experimental treatment uses genetically engineered astrocytes — abundant support cells in the brain — that are equipped with a CAR “homing device” similar to those used in cancer immunotherapy. Wed, 11 Mar 2026 17:01:42 EDT https://www.sciencedaily.com/releases/2026/03/260311004720.htm https://www.sciencedaily.com/releases/2026/03/260307213244.htm A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly used drug for severe agitation. Researchers found the antipsychotic increases stroke risk in dementia patients across the board—including those with no prior heart disease or stroke—challenging the long-held belief that some patients might be safer candidates than others. Because risperidone is the only drug of its type licensed for dementia, doctors often use it as a last resort when distressing symptoms become unmanageable. Sun, 08 Mar 2026 16:45:01 EDT https://www.sciencedaily.com/releases/2026/03/260307213244.htm https://www.sciencedaily.com/releases/2026/03/260307155945.htm Scientists have uncovered a surprising new role for little-known brain cells called tanycytes that may influence the development of Alzheimer’s disease. These specialized cells appear to help remove toxic tau protein from the brain by transporting it from the cerebrospinal fluid into the bloodstream. When tanycytes become damaged or dysfunctional, tau can accumulate in the brain, a hallmark of Alzheimer’s. Sun, 08 Mar 2026 06:14:34 EDT https://www.sciencedaily.com/releases/2026/03/260307155945.htm https://www.sciencedaily.com/releases/2026/03/260303145730.htm A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments. Tue, 03 Mar 2026 21:38:45 EST https://www.sciencedaily.com/releases/2026/03/260303145730.htm https://www.sciencedaily.com/releases/2026/02/260228093505.htm Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining laser-based imaging with machine learning, they uncovered chemical changes that spread unevenly across the brain and extend beyond amyloid plaques. Key memory regions showed major shifts in cholesterol and energy-related molecules. The findings hint that Alzheimer’s is a whole-brain metabolic disruption—not just a protein problem. Sun, 01 Mar 2026 10:16:01 EST https://www.sciencedaily.com/releases/2026/02/260228093505.htm https://www.sciencedaily.com/releases/2026/02/260224023159.htm Subtle changes in brain blood flow and oxygen use are closely linked to hallmark signs of Alzheimer’s, including amyloid plaques and memory-related brain shrinkage. Simple, noninvasive scans may one day help spot risk earlier—by looking at the brain’s vascular health, not just its plaques. Tue, 24 Feb 2026 10:21:58 EST https://www.sciencedaily.com/releases/2026/02/260224023159.htm https://www.sciencedaily.com/releases/2026/02/260222085203.htm Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care. Mon, 23 Feb 2026 06:46:07 EST https://www.sciencedaily.com/releases/2026/02/260222085203.htm https://www.sciencedaily.com/releases/2026/02/260221000321.htm A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina and brain, where it sparks inflammation, nerve cell death, and the buildup of amyloid-beta—the hallmark protein linked to Alzheimer’s. Higher levels of the bacterium were found in people with Alzheimer’s, especially those carrying the high-risk APOE4 gene, and were tied to more severe cognitive decline. Sat, 21 Feb 2026 00:43:23 EST https://www.sciencedaily.com/releases/2026/02/260221000321.htm https://www.sciencedaily.com/releases/2026/02/260220010836.htm Breathing polluted air may do more than harm your lungs — it could also increase your risk of Alzheimer’s disease. In a sweeping study of nearly 28 million older Americans, researchers found that long term exposure to fine particle air pollution was linked to a higher likelihood of developing Alzheimer’s. The connection appeared to stem largely from pollution’s direct effects on the brain, rather than through related health conditions like hypertension or depression. Fri, 20 Feb 2026 01:47:05 EST https://www.sciencedaily.com/releases/2026/02/260220010836.htm https://www.sciencedaily.com/releases/2026/02/260219040820.htm A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is driven by the gradual loss of dopamine-producing cells—leading to tremors, stiffness, and slowed movement—researchers are implanting lab-grown cells directly into the brain’s movement center to replace what’s been lost. Fri, 20 Feb 2026 04:03:58 EST https://www.sciencedaily.com/releases/2026/02/260219040820.htm https://www.sciencedaily.com/releases/2026/02/260219040752.htm Exercise may sharpen the mind by repairing the brain’s protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein causing the blood-brain barrier to become leaky with age. In older mice, dialing down this protein reduced inflammation and improved memory. The discovery points to a surprising body-to-brain pathway that could inspire new Alzheimer’s therapies. Fri, 20 Feb 2026 10:19:43 EST https://www.sciencedaily.com/releases/2026/02/260219040752.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260215225555.htm Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects. Tue, 17 Feb 2026 05:30:08 EST https://www.sciencedaily.com/releases/2026/02/260215225555.htm https://www.sciencedaily.com/releases/2026/02/260215084954.htm Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team uncovered cause-and-effect relationships between genes across six major brain cell types, revealing which genes are truly driving harmful changes. The most dramatic disruptions were found in excitatory neurons, where thousands of genetic interactions appear to be extensively rewired as the disease progresses. Sun, 15 Feb 2026 09:15:19 EST https://www.sciencedaily.com/releases/2026/02/260215084954.htm https://www.sciencedaily.com/releases/2026/02/260212234218.htm Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that special support cells called astrocytes—located far from the actual injury—spring into action after damage. These “lesion-remote astrocytes” send out a protein signal, CCN1, that reprograms immune cells to efficiently clean up fatty nerve debris. Fri, 13 Feb 2026 08:47:43 EST https://www.sciencedaily.com/releases/2026/02/260212234218.htm https://www.sciencedaily.com/releases/2026/02/260211073023.htm A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, those who completed five to six weeks of adaptive “speed of processing” training — along with a few booster sessions — were significantly less likely to develop dementia, including Alzheimer’s disease, even two decades later. Participants who received the boosted speed training had a 25% lower dementia risk compared to those who received no training, making it the only intervention in the trial to show such a lasting protective effect. Wed, 11 Feb 2026 22:15:24 EST https://www.sciencedaily.com/releases/2026/02/260211073023.htm https://www.sciencedaily.com/releases/2026/02/260210040623.htm Depression in older adults may sometimes signal the early stages of Parkinson’s disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains elevated long afterward, unlike in other chronic illnesses. This suggests depression may reflect early brain changes rather than emotional distress alone. Wed, 11 Feb 2026 06:57:31 EST https://www.sciencedaily.com/releases/2026/02/260210040623.htm https://www.sciencedaily.com/releases/2026/02/260209064310.htm A long-term study found that women who closely followed a Mediterranean diet had a much lower risk of stroke. The strongest benefits were seen in women who ate more plant-based foods, fish, and olive oil while cutting back on red meat and saturated fats. Their risk dropped across all major stroke types, including bleeding strokes, which are less commonly studied. The findings suggest diet may be a powerful but overlooked factor in stroke prevention. Mon, 09 Feb 2026 06:54:46 EST https://www.sciencedaily.com/releases/2026/02/260209064310.htm https://www.sciencedaily.com/releases/2026/02/260208203013.htm A new international study points to a specific brain network as the core driver of Parkinson’s disease. Scientists found that this network becomes overly connected, disrupting not just movement but also thinking and other bodily functions. When researchers targeted it with non-invasive brain stimulation, patients showed much stronger symptom improvement than with conventional stimulation. The discovery could reshape how Parkinson’s is diagnosed and treated. Sun, 08 Feb 2026 20:37:23 EST https://www.sciencedaily.com/releases/2026/02/260208203013.htm https://www.sciencedaily.com/releases/2026/02/260206012213.htm Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease. Using advanced computer modeling, researchers discovered that beta-sitosterol—a natural plant compound—strongly interacts with two key enzymes involved in memory loss and cognitive decline. The compound showed stability, strong binding, and favorable safety indicators, making it a standout candidate for future drug development. Sun, 08 Feb 2026 07:57:41 EST https://www.sciencedaily.com/releases/2026/02/260206012213.htm https://www.sciencedaily.com/releases/2026/02/260206012203.htm Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The early-stage clinical trial involves implanting lab-grown dopamine-producing cells directly into a key movement-control region of the brain, with the hope of slowing disease progression and improving motor function. Fri, 06 Feb 2026 06:57:35 EST https://www.sciencedaily.com/releases/2026/02/260206012203.htm https://www.sciencedaily.com/releases/2026/02/260203030554.htm Scientists still don’t know how the brain turns physical activity into thoughts, feelings, and awareness—but a powerful new tool may help crack the mystery. Researchers at MIT are exploring transcranial focused ultrasound, a noninvasive technology that can precisely stimulate deep regions of the brain that were previously off-limits. In a new “roadmap” paper, they explain how this method could finally let scientists test cause-and-effect in consciousness research, not just observe correlations. Wed, 04 Feb 2026 07:42:40 EST https://www.sciencedaily.com/releases/2026/02/260203030554.htm https://www.sciencedaily.com/releases/2026/02/260201062459.htm When the brain rests, it usually replays recent experiences to strengthen memory. Scientists found that in Alzheimer’s-like mice, this replay still occurs — but the signals are jumbled and poorly coordinated. As a result, memory-supporting brain cells lose their stability, and the animals struggle to remember where they’ve been. Sun, 01 Feb 2026 10:41:29 EST https://www.sciencedaily.com/releases/2026/02/260201062459.htm https://www.sciencedaily.com/releases/2026/02/260201062457.htm Middle age is becoming a tougher chapter for many Americans, especially those born in the 1960s and early 1970s. Compared with earlier generations, they report more loneliness and depression, along with weaker physical strength and declining memory. These troubling trends stand out internationally, as similar declines are largely absent in other wealthy nations, particularly in Nordic Europe, where midlife well-being has improved. Sun, 01 Feb 2026 10:25:53 EST https://www.sciencedaily.com/releases/2026/02/260201062457.htm https://www.sciencedaily.com/releases/2026/01/260129080424.htm Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in the blood tied to how cells handle stress and repair DNA, the team identified a brief early window when Parkinson’s quietly leaves a measurable fingerprint. Thu, 29 Jan 2026 09:26:14 EST https://www.sciencedaily.com/releases/2026/01/260129080424.htm https://www.sciencedaily.com/releases/2026/01/260125083413.htm Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same receptor, triggering synapse loss. Surprisingly, neurons aren’t passive victims—they actively respond to these signals. Targeting this receptor could offer a new way to protect memory beyond current amyloid-focused drugs. Mon, 26 Jan 2026 03:08:27 EST https://www.sciencedaily.com/releases/2026/01/260125083413.htm https://www.sciencedaily.com/releases/2026/01/260124073920.htm A large, decades-long study suggests that signs of ADHD in childhood may have consequences that extend well beyond school and behavior. Researchers followed nearly 11,000 people from childhood into midlife and found that those with strong ADHD traits at age 10 were more likely to experience multiple physical health problems and health-related disability by their mid-40s. Sat, 24 Jan 2026 07:39:20 EST https://www.sciencedaily.com/releases/2026/01/260124073920.htm https://www.sciencedaily.com/releases/2026/01/260124003829.htm Researchers have found that a natural aging-related molecule can repair key memory processes affected by Alzheimer’s disease. The compound improves communication between brain cells and restores early memory abilities that typically fade first. Because it already exists in the body and declines with age, boosting it may offer a safer way to protect the brain. The discovery hints at a new strategy for slowing cognitive ageing before severe damage sets in. Sun, 25 Jan 2026 02:17:02 EST https://www.sciencedaily.com/releases/2026/01/260124003829.htm https://www.sciencedaily.com/releases/2026/01/260122093435.htm A new study reveals that super agers over 80 have a distinct genetic edge. They are much less likely to carry the gene most associated with Alzheimer’s risk, even when compared with other healthy seniors. Researchers also found higher levels of a protective gene variant in this group. Together, the findings help explain why some people age with remarkably youthful minds. Thu, 22 Jan 2026 09:41:30 EST https://www.sciencedaily.com/releases/2026/01/260122093435.htm https://www.sciencedaily.com/releases/2026/01/260122073623.htm Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene — even including a common version once considered neutral. The discovery reshapes how scientists think about risk and prevention. It also highlights a major opportunity for new treatments aimed at a single biological pathway. Fri, 23 Jan 2026 10:16:38 EST https://www.sciencedaily.com/releases/2026/01/260122073623.htm https://www.sciencedaily.com/releases/2026/01/260120095111.htm Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy systems. They designed a new treatment that intercepts this harmful process, protecting brain cells and restoring their function. In lab and animal models, the approach improved movement and cognitive performance while reducing inflammation. The findings point toward a new generation of Parkinson’s therapies aimed at the root cause, not just the symptoms. Tue, 20 Jan 2026 10:08:47 EST https://www.sciencedaily.com/releases/2026/01/260120095111.htm https://www.sciencedaily.com/releases/2026/01/260118233547.htm Cannabis-based medicines have been widely promoted as a potential answer for people living with chronic nerve pain—but a major new review finds the evidence just isn’t there yet. After analyzing more than 20 clinical trials involving over 2,100 adults, researchers found no strong proof that cannabis products outperform placebos in relieving neuropathic pain. Even when small improvements were reported, especially with THC-CBD combinations, they weren’t large enough to make a real difference in daily life. Mon, 19 Jan 2026 00:11:47 EST https://www.sciencedaily.com/releases/2026/01/260118233547.htm https://www.sciencedaily.com/releases/2026/01/260116035348.htm Researchers have identified OTULIN, an immune-regulating enzyme, as a key trigger of tau buildup in the brain. When OTULIN was disabled, tau vanished from neurons and brain cells remained healthy. The findings challenge long-held assumptions about tau’s necessity and highlight a promising new path for fighting Alzheimer’s and brain aging. Scientists now believe OTULIN may act as a master switch for inflammation and age-related brain decline. Fri, 16 Jan 2026 03:53:48 EST https://www.sciencedaily.com/releases/2026/01/260116035348.htm https://www.sciencedaily.com/releases/2026/01/260112001041.htm Researchers have discovered a brain activity pattern that can predict which people with mild cognitive impairment are likely to develop Alzheimer’s disease. Using a noninvasive brain scanning technique and a custom analysis tool, they detected subtle changes in electrical signals tied to memory processing years before diagnosis. The findings point to a new way of spotting Alzheimer’s early—by listening directly to how neurons behave. Mon, 12 Jan 2026 09:24:19 EST https://www.sciencedaily.com/releases/2026/01/260112001041.htm https://www.sciencedaily.com/releases/2026/01/260106001916.htm A familiar mouth bacterium best known for causing cavities may also be quietly influencing the brain. Scientists found that when this microbe settles in the gut, it produces compounds that can travel through the bloodstream and harm neurons involved in movement. In animal studies, this process triggered inflammation, motor problems, and brain changes linked to Parkinson’s disease. The findings hint that protecting oral and gut health could help protect the brain as well. Tue, 06 Jan 2026 22:25:32 EST https://www.sciencedaily.com/releases/2026/01/260106001916.htm https://www.sciencedaily.com/releases/2025/12/251228074455.htm Feeling warm or cold doesn’t just register on the skin—it changes how connected we feel to our own bodies. Research shows that temperature sensations help shape body ownership, emotional regulation, and mental well-being. Disruptions in thermal perception are linked to conditions like depression, trauma, and stroke-related body disconnect. These insights could lead to new sensory-based mental health treatments and more lifelike prosthetics. Sun, 04 Jan 2026 18:17:24 EST https://www.sciencedaily.com/releases/2025/12/251228074455.htm https://www.sciencedaily.com/releases/2025/12/251228074451.htm Tiny lab-grown brains are offering an unprecedented look at how schizophrenia and bipolar disorder disrupt neural activity. Researchers found distinct electrical firing patterns that could identify these conditions with high accuracy. The discovery opens the door to more precise diagnoses and personalized drug testing. Instead of guessing medications, doctors may one day see what works before treating the patient. Sun, 28 Dec 2025 07:44:51 EST https://www.sciencedaily.com/releases/2025/12/251228074451.htm https://www.sciencedaily.com/releases/2025/12/251228020016.htm Researchers discovered that clogged brain “drains” show up early in people at risk of Alzheimer’s disease. These blockages, easily seen on standard MRI scans, are tied to toxic protein buildup linked to memory loss and cognitive decline. In some cases, they may signal Alzheimer’s earlier than other commonly used brain markers. This could help physicians detect the disease earlier, before irreversible damage sets in. Sat, 03 Jan 2026 00:45:11 EST https://www.sciencedaily.com/releases/2025/12/251228020016.htm https://www.sciencedaily.com/releases/2025/12/251227082722.htm A major new review has put hundreds of alternative autism treatments under the microscope—and most didn’t hold up. Scientists analyzed decades of research and found little reliable evidence that popular approaches like probiotics, acupuncture, or music therapy truly work. Alarmingly, safety was often ignored, with many treatments never properly evaluated for side effects. The researchers stress that looking at the full body of evidence matters far more than trusting a single hopeful study. Sun, 28 Dec 2025 01:32:17 EST https://www.sciencedaily.com/releases/2025/12/251227082722.htm https://www.sciencedaily.com/releases/2025/12/251227004153.htm Scientists studying Alzheimer’s in African Americans have uncovered a striking genetic clue that may cut across racial lines. In brain tissue from more than 200 donors, the gene ADAMTS2 was significantly more active in people with Alzheimer’s than in those without it. Even more surprising, this same gene topped the list in an independent study of White individuals. The discovery hints at a common biological pathway behind Alzheimer’s and opens the door to new treatment strategies. Thu, 01 Jan 2026 11:23:26 EST https://www.sciencedaily.com/releases/2025/12/251227004153.htm https://www.sciencedaily.com/releases/2025/12/251225031247.htm A new study suggests that dementia may be driven in part by faulty blood flow in the brain. Researchers found that losing a key lipid causes blood vessels to become overactive, disrupting circulation and starving brain tissue. When the missing molecule was restored, normal blood flow returned. This discovery opens the door to new treatments aimed at fixing vascular problems in dementia. Thu, 25 Dec 2025 03:42:52 EST https://www.sciencedaily.com/releases/2025/12/251225031247.htm https://www.sciencedaily.com/releases/2025/12/251224032354.htm Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and restoring that balance can reverse damage, even in advanced cases. In mouse models, treatment repaired brain pathology, restored cognitive function, and normalized Alzheimer’s biomarkers. The results offer fresh hope that recovery may be possible. Wed, 24 Dec 2025 10:14:26 EST https://www.sciencedaily.com/releases/2025/12/251224032354.htm https://www.sciencedaily.com/releases/2025/12/251224015651.htm Cannabis products with higher THC levels may slightly reduce chronic pain, particularly nerve pain, according to a review of multiple clinical trials. The improvement was small and short-lived, while side effects were more common. Products with little or no THC, including CBD-only formulations, showed no clear benefit. Researchers say more long-term studies are needed. Tue, 30 Dec 2025 20:44:59 EST https://www.sciencedaily.com/releases/2025/12/251224015651.htm